Extracorporeal Shock Wave Lithotripsy companies

  • Report ID: 3932
  • Published Date: Apr 18, 2025
  • Report Format: PDF, PPT

Companies Dominating the Extracorporeal Shock Wave Lithotripsy (ESWL) Landscape

    • Siemens AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boston Scientific Corporation
    • C.R. Bard Inc.
    • Cook Group Inc.
    • Medtrue Enterprise Co. Ltd.
    • Jiangsu Sainty Handsome Co., Ltd.
    • Lumenis LTD
    • Olympus Corporation
    • Dornier MedTech GmbH
    • Karl Storz Gmbh and Co. KG

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

2025 Extracorporeal Shock Wave Lithotripsy Market is assessed at USD 468.08 million.

The global extracorporeal shock wave lithotripsy market size was valued at over USD 447.32 million in 2024 and is expected to grow at a CAGR of more than 5.8%, surpassing USD 930.96 million by 2037.

North America is projected to attain USD 297.91 million by 2037, driven by a large number of diabetic and obese patients prone to kidney stones and gallstones, supported by a strong healthcare network and regulatory backing.

The major players in the market are Siemens AG, Boston Scientific Corporation, C.R. Bard Inc., Cook Group Inc., Medtrue Enterprise Co. Ltd., Jiangsu Sainty Handsome Co., Ltd., Lumenis LTD, Olympus Corporation, Dornier MedTech GmbH, Karl Storz Gmbh and Co. KG
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos